SEC Info - Innoviva, Inc., et al. - ‘SC 13D/A’ on 2/1/22 re: Entasis Therapeutics Holdings Inc.

SEC Info℠

Home

Help

Please Sign In

Innoviva, Inc., et al. – ‘SC 13D/A’ on 2/1/22 re: Entasis Therapeutics Holdings Inc.

On: Tuesday, 2/1/22, at 6:34pm ET · As of: 2/2/22 · Accession #: 899140-22-118 · File #: 5-90651

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/02/22  Innoviva, Inc.                    SC 13D/A    2/01/22    2:88K  Entasis Theraps Holdings Inc.     Willkie Farr & Gallagher
          Innoviva Strategic Opportunities LLC

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Schedule 13D/A, #6                                  HTML     25K 
 2: EX-11       Proposal to Members of Board of Directors of the    HTML      9K 
                Issuer

Filing Submission 0000899140-22-000118 – SGML Text

Original SGML Text submitted by:	Willkie Farr & Gallagher (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Innoviva, Inc., et al. – ‘SC 13D/A’ on 2/1/22 re: Entasis Therapeutics Holdings Inc.

On: Tuesday, 2/1/22, at 6:34pm ET · As of: 2/2/22 · Accession #: 899140-22-118 · File #: 5-90651

Previous ‘SC 13D’: ‘SC 13D/A’ on 11/1/21 · Next: ‘SC 13D/A’ on 2/11/22 · Latest: ‘SC 13D/A’ on 3/4/24

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68Filing Table of Contents

To view the SGML, please refresh this page.

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents

To view the SGML, please refresh
this page.